ORD 59318/2024

—·EP4026488: TRANSCUTANEOUS ANALYTE SENSOR SYSTEMS AND METHODS

Case details: Status
—
Action
Procedural application
Category
Case Management Orders
Parties: Claimants
DexCom, Inc.
Reps: Markus Grosch (Quinn Emanuel Urquhart & Sullivan LLP); Johannes Bukow (Quinn Emanuel Urquhart & Sullivan LLP); Jan Axtmann (Quinn Emanuel Urquhart & Sullivan LLP); Paul Lehmann (Quinn Emanuel Urquhart & Sullivan LLP)
Respondents
Abbott Logistics B.V.
Abbott Laboratories GmbH
Abbott Laboratories
Abbott Oy
Abbott Scandinavia Aktiebolag
Abbott (S.A./N.V.)
Abbott B.V.
Abbott France (S.A.S.)
Abbott GmbH
Abbott Diagnostics GmbH
Abbott Gesellschaft m.b.H.
Abbott Diabetes Care Inc.
Abbott s.r.l.
Reps: Dietrich Kamlah (Taylor Wessing); Christian Lederer (Taylor Wessing); Gisbert Hohagen (Taylor Wessing)
Division: Dusseldorf LD
Judges: Berenice Thom · Legally Qualified Judge
Petri Rinkinen · Legally Qualified Judge
Technology: Pharmaceutical & Medical
Language: —
First decided: Nov 21, 2024

Decisions

2024-11-21
Generic Order
The Düsseldorf Local Division issued a procedural order in the DexCom v. Abbott infringement action concerning EP 4 026 488, taking an early decision pursuant to R. 37.2 RoP on how to proceed under Art. 33(3) UPCA (bifurcation or combined hearing of infringement and validity). The court exercised its discretion to hear both the infringement action and any counterclaim for revocation together.
Legal issues:Early decision on Art. 33(3) UPCA bifurcation (R. 37.2 RoP)Combined hearing of infringement and revocationJurisdiction and case management in large multi-party infringement actions

Documents